ArticleJournal of hematology2020
Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia.
Joseph Tuscano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleJournal of hematology2020
Joseph Tuscano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.